
Dyne Therapeutics
DYN
Reported
Thursday, February 27
Q4 2024 Earnings
(USD) | Expected | Reported | Surprise $ | Surprise % |
---|---|---|---|---|
EPS | -0.75 | -0.88 | -0.13 | -17.33% |
Revenue | - | 0.00 | - | - |
WhatIF - Earnings
EPS Missed Expectations by -$0.13

Dyne Therapeutics (DYN:NASDAQ) has never missed EPS by this much before
There’s a first time for everything